论文信息 - A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101) - 字舞流文

A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)

U. Banerji | J. Powderly | N. Lakhani | N. Bourayou | Drew Rasco | Rasha Cosman | Chuan Tian | Monika Tomaszewska-Kiecana | Elena Garralda | Deanna Kornacki | Jia Li | D. Rasco | C. Tian